Variant report
Variant | esv3410145 |
---|---|
Chromosome Location | chr6:165395590-165416763 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568238259 | chr6:165404219-165404220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529089729 | chr6:165404223-165404224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146300928 | chr6:165404252-165404253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575274079 | chr6:165404272-165404273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569194205 | chr6:165404290-165404291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35187665 | chr6:165404298-165404299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539806604 | chr6:165404331-165404332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189845877 | chr6:165404339-165404340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144480389 | chr6:165404372-165404373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566899878 | chr6:165404378-165404379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534297239 | chr6:165404399-165404400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148508976 | chr6:165404406-165404407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553129374 | chr6:165404416-165404417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9347058 | chr6:165404455-165404456 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs556782962 | chr6:165404483-165404484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577902001 | chr6:165404554-165404555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142198223 | chr6:165404577-165404578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557899510 | chr6:165404600-165404601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572548142 | chr6:165404634-165404635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180718113 | chr6:165404653-165404654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs117836495 | chr6:165404736-165404737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561633134 | chr6:165404841-165404842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs60762728 | chr6:165404863-165404864 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs550514788 | chr6:165404881-165404882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs28539262 | chr6:165404917-165404918 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs533238287 | chr6:165404920-165404921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551747018 | chr6:165404921-165404922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs151226457 | chr6:165404973-165404974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184642696 | chr6:165404974-165404975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575944519 | chr6:165404979-165404980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9347973 | chr6:165404997-165404998 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs567671046 | chr6:165404999-165405000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140269681 | chr6:165405028-165405029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556317811 | chr6:165405032-165405033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577866711 | chr6:165405035-165405036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73020964 | chr6:165405049-165405050 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs574003988 | chr6:165405050-165405051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9347974 | chr6:165405056-165405057 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs145215192 | chr6:165405057-165405058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs377194815 | chr6:165405094-165405095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74496096 | chr6:165405101-165405102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9365845 | chr6:165405102-165405103 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs544320053 | chr6:165405116-165405117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9356330 | chr6:165405131-165405132 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs374236894 | chr6:165405135-165405136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147624744 | chr6:165405136-165405137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9347975 | chr6:165405152-165405153 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs77611278 | chr6:165405210-165405211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567680144 | chr6:165405296-165405297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9356331 | chr6:165405313-165405314 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:165404200-165406200 | Enhancers | Placenta | Placenta |
2 | chr6:165405000-165406200 | Enhancers | Placenta Amnion | Placenta Amnion |
3 | chr6:165408200-165408400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr6:165408400-165410200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr6:165410200-165410600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr6:165410400-165411000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |